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Controllable pore size and architecture are essential properties for tissue+engineering 
scaffolds to support cell ingrowth colonization. To investigate the effect of PEG addition on 
porosity and bone+cell behavior, porous Polylactic acid (PLA)+Polyethylene glycol (PEG) 
scaffolds were developed with varied weight ratios of PLA+PEG (100/0, 90/10, 75/25) using 
solvent casting and porogen leaching. Sugar 200+300 µm in size was used as a porogen. To 
assess their suitability for bone tissue engineering, MLO+A5 murine osteoblast cells were 
cultured and cell metabolic activity, alkaline phosphatase (ALP) activity and bone+matrix 
production determined (alizarin red S staining for calcium, direct red 80 staining for 
collagen). It was found that metabolic activity was significantly higher over time on scaffolds 
containing PEG, ALP activity and mineralized matrix production were also significantly 
higher on scaffolds containing 25% PEG. Porous architecture and cell distribution and 
penetration into the scaffold were analyzed using SEM and confocal microscopy, revealing 
that inclusion of PEG increased pore interconnectivity and therefore cell ingrowth in 
comparison to pure PLA scaffolds. The results of this study confirmed that PLA+PEG porous 
scaffolds support mineralizing osteoblasts better than pure PLA scaffolds, indicating they 
have a high potential for use in bone tissue engineering applications.  
"	#
! Polylactic acid (PLA), Polyethene glycol (PEG), Bone tissue engineering, MLO+
A5, porosity. 
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Bone tissue engineering aims to combine scaffolds, osteoblasts and physiochemical factors to 
regenerate healthy bone tissue. The scaffold material plays a vital role in the development of 
engineered bone, and it should possess a highly porous structure that promotes cell 
attachment, proliferation and bone tissue formation and mineralization [1]. Synthetic and 
natural polymeric scaffolds can be used as a bone tissue+engineering scaffold. The advantage 
of synthetic polymer scaffolds is their customizable chemical, physical and mechanical 
properties. Many biocompatible and biodegradable synthetic scaffolds have been developed 
for bone tissue engineering applications, such as polylactic acid (PLA), poly lactide+co+
glycolide (PLGA), polycaprolactone (PCL) and polyurethane (PU) [2]–[4]. Porogen and 
polymer composition determine the nature of the porous structure of the scaffolds; for 
example pore size, shape and interconectivity.  The porosity of the scaffold facilitates cell 
migration, ingrowth, and effective nutrient distribution and waste removal. Therefore, 
appropriate scaffold porosity is essential for successful tissue engineering. Numerous 
methods have been developed to introduce porosity into scaffold materials, including solvent 
casting+particulate leaching [5], supercritical CO2 gas foaming and particulate leaching [6], 
emulsion freezing/freeze+drying [7], and emulsion templating [8]. The solvent casting+
particulate leaching technique is widely accepted as a simple, cost+effective method to 
provide a porous architecture within the scaffold [9].	 Sodium chloride, ammonium 
bicarbonate, and glucose with different crystal sizes have all been used as porogens to 
fabricate porous scaffolds, and the porosity of scaffold can be controlled by the amount and 
dimensions of the porogen [10]–[13].  
Inclusion of PLA is an excellent way of modifying the mechanical properties and the 
degradation rate when developing biomaterials for specific applications. PEG is also an 
effective modifier, as it is non+toxic and biocompatibile [14]–[16]. Due to its solubility in 
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water, the degradation can be controlled for different biomedical applications. For tissue 
engineering, degradation rate is a vital parameter as it should match the rate of tissue 
formation, therefore; in the current study PEG is used to develop porous PLA/PEG scaffolds.  
It has previously been shown that the degradation rate of PLA/PEG scaffolds is enhanced 
with increasing PEG content [10]. 
MLO+A5 are an immortal clonal murine osteoblast cell line  capable of rapidly depositing 
mineralised extracellular matrix in sheets rather than nodules [17]. They have very high ALP 
activity and expression of bone sialoprotein and osteocalcin, all hallmarks of the post+
osteoblast phenotype [18]. Due to their high rate of bone matrix production in comparison to 
other murine bone cell lines, such as MC3T3+E1, they have been used extensively for 
studying bone cell behaviour and assessing bone tissue engineering scaffolds [1], [19], [20]. 
Previous studies have reported on the degradation and mechanical properties of PLA+PEG 
scaffolds [10], [21] and it was reported that addition of PEG to PLA changed the 
crystallization and the rheological behavior of the matrix, decreased Tg, facilitated the 
spherullitic growth (growth of spherical crystalline regions), reduced the elastic and viscous 
behavior and enhanced crystallization properties to increase the open+pore and pore density. 
However, little is known about the ability of such scaffolds to support bone cell growth. 
Therefore, in this study, we synthesized solvent cast/porogen leached polylactic acid (PLA)+
poly ethylene glycol (PEG) porous scaffolds and varied the overall porosity by modulating 
the PEG: PLA ratio. We evaluated the morphological variation and cell penetration of 
different PLA+PEG scaffolds and tested the compatibility and ability to support bone matrix 
deposition using MLO+A5 osteoblastic cells.   
 
 
Page 4 of 23
John Wiley & Sons, Inc.
Journal of Biomedical Materials Research: Part A
This article is protected by copyright. All rights reserved.
 '%	(
		(!	
'%$%	(
	
Polylactic acid (PLA4042D) (NatureWorks®, USA), Polyethylene glycol (PEG4000), 
Dichloromethane (Fisher Chemicals, UK), α+minimal expansion media (α+MEM) (Lonza, 
UK), Fetal Bovine serum (FBS), Penicillin+Streptomycin+Glutamine (PSG), Resazurin Red 
Salt, Alkaline phosphatase kit (Thermo Fisher Scientific, UK), Alizarin Red S Salt, Direct 
Red 80.  All chemicals and reagents were obtained from Sigma+Aldrich, UK unless otherwise 
stated. 
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Different weight ratios of PLA and PEG (100/0, 90/10 and 75/25 weight %) were dissolved 
in dichloromethane. Polymer solutions were mixed with caster sugar (Tesco PLC, UK) (200+
300 µm) in the weight/weight ratio of 1:9 and poured into Petri dishes for solvent evaporation 
for 48 h in a fume cupboard before using a vacuum to remove the remaining solvent. To 
leach the sugar particles scaffolds were immersed in diH2O for 72 h with the water replaced 
every 6 h. Scaffolds were then dried under vacuum for 48 h. Circular disks of diameter 1 cm 
were cut using a laser cutter (Mini 19 Laser, Epilog Laser, UK) for cell culture studies. In this 
study, 100% of PLA, 90/10+ PLA/PEG, and 75/25+PLA/PEG are represented as PLA100, 
PLA90 and PLA75 respectively.  
'%*%	(+ ,		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Scaffolds were sterilized by immersion in 70% ethanol for two days and then washed thrice 
with sterile PBS before submerging in basal media (BM) (α+MEM, 10% FBS, 1% PSG) for 
two days to allow proteins to adsorb to the surface to improve cell attachment. Then, 2×10
4
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MLO+A5 (Kindly donated by Dr. Lynda Bonewald, University of Missouri) cells of passage 
number 52 were seeded on each scaffold (Scaffold size; diameter ×thickness=10mm×4mm) 
and left for 2 h before submerging in 2 mL of BM and incubating overnight. Scaffolds were 
transferred to a 12 well plate on day 1 so that only cells attached to the scaffold were 
cultured, and were maintained in supplemented media (BM + 5 mM β+glycerolphosphate 
(βGP), 50 µg/mL ascorbic acid+2+phosphate (AA+2P) to facilitate bone matrix production for 
the remainder of the experiment. The media was exchanged every 2+3 days.    
'%-%	./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Cell metabolic activity was elucidated by RR assay and used to estimate cell number. 
Scaffolds were transferred to new well plates and 2mL of RR working solution (10 vol% of 
RR stock solution (1 mM resazurin sodium salt in diH2O) in BM) was added before 
incubating for 4 h. Seeding wells were also assayed to determine seeding efficiency. 200 µL 
of the reduced working solution was transferred to a clear 96 well plate and fluorescence 
readings at excitation wavelength 540 nm, and emission wavelength 590 nm (Tecan infinite 
200+pro) were taken. Excess working solution was removed and the samples were washed 
twice with PBS to remove residual working solution trapped within the scaffold before 
adding fresh media. 
'%,	0				
Culture media was removed from the scaffolds which were then washed twice with PBS. 
Scaffolds were transferred to 1.5 mL tubes and 1 mL of cell digestion buffer (10 v/v% cell 
assay buffer (1.5 M Tris–HCl, 1 mM ZnCl2, 1 mM MgCl2 in deionized water (diH2O), 1% 
TritonX100, in diH2O)) was added and incubated for 30 min before storing at 4 °C overnight. 
Samples were vortexed for 15 seconds and a freeze+thaw cycle was performed three times (+
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80 °C 10 min, 37 °C 15 min) to facilitate cell digestion by ice crystal formation. Finally, 
samples were centrifuged at 10,000 rpm for 5 min.  
180 µL of PNPP Phosphatase Substrate (Thermo Scientiﬁc, UK) was added in a clear 96 well 
plate and combined with 20 µL cell lysate. The well plate was then immediately added to the 
plate reader and absorbance readings were taken at a wavelength of 405 nm every minute for 
30 min. ALP activity was expressed as nmol of p+nitrophenol per minute (nmol pNP/min), 
assuming that one absorbance value equals 19.75 nmol of the product.  
'%1%	23		
The amount of double standard DNA is an indicator of cell number, which can be calculated 
using the quant+iT
™
 dsDNA assay kit (Thermo Scientiﬁc, UK). 10 µL of cell lysate was 
combined with 90 µL of working solution in an opaque well plate, wrapped in well plate and 
incubated at room temperature for 10 min to allow the DNA and dye to conjugate. 
Fluorescence readings were taken at an excitation wavelength of 485 nm and an emission 
wavelength of 535 nm. Fluorescence values were converted to ng of DNA with a standard 
curve. 
'%4	5
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Scaffolds were fixed prior to Alizarin Red S (ARS) and DR80 staining and confocal imaging. 
Fixing was performed by removing the culture media and washing twice with PBS. Samples 
were then submerged in 3.7% formaldehyde for 30 minutes before rinsing a further two times 
in PBS. Samples were stored at 4 °C in PBS until use. 	
'%6%	/
	.	)	)		.)	
Calcium deposition by the cells was measured using Alizarin Red S. The samples were 
washed twice with diH2O, and then 2mL of ARS working solution (1 w/v% ARS dissolved in 
diH2O) was added to each scaffold, incubated for 30 min. ARS solution was removed and 
Page 7 of 23
John Wiley & Sons, Inc.
Journal of Biomedical Materials Research: Part A
This article is protected by copyright. All rights reserved.
they were washed with diH2O every five minutes with gentle orbital shaking, continued until 
the water remained clear.  5% of perchloric acid was added to each sample to destain the 
samples, left for 15 min with gentle orbital shaking. 150 µL of destained solution was taken 
to measure the absorbance readings at a wavelength of 405 nm. These absorbance values 
were converted to concentration of ARS ((µg/mL) using standard curve.   
'%7%	2
	.	68	)	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Total collagen content was detected by using DR80 assay. The samples were washed thrice 
with water after performing the ARS assay and then 2 mL of DR80 working solution (1 
w/v% direct red 80 in saturated picric acid) was added to each sample, then left for 18h with 
orbital shaking at 100 rpm. 0.2 M sodium hydroxide: methanol (1:1) was added to destain the 
samples and left for 20 min with orbital shaking at 100 rpm.  The absorbance of 150 µL of 
destained solution was measured using a plate reader at 405 nm. The DR80 concentration 
was (µg/mL) calculated using a standard curve.  
'%$8%		&		
To prepare fixed samples for imaging they were immersed in Immunocytochemistry (ICC) 
buffer (1% BSA, 0.1% Triton X+100 in PBS) for 20 min. Scaffolds were submerged in 0.2% 
Propidium Iodide (PI) and 1% Phalloidin FITC (1:1000 in ICC buffer) working solution and 
wrapped in foil, for 3h. The stain was removed from the sample and washed with PBS. 
Samples were stored wrapped foil at 4 °C in PBS until use. 
Confocal images (512 x 512 pixels) were obtained using a Zeiss LSM 
510Meta upright confocal microscope with 10x objective (EC Plan+Neofluar 10X/0.30, Carl 
Zeiss Ltd, UK), with a pixel dwell time of 2.56 µs. Propidium Iodide (PI) was excited using 
a laser wavelength of 543 nm and Phalloidin+FITC detected using a wavelength 488 nm. 
Scaffold 3D images were produced using Z+stacking, with 35 images taken at 6.4 µm. 
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Scanning electron microscopy (SEM) was used to examine the porosity and cell penetration 
into PLA+PEG scaffolds. To prepare seeded samples for imaging, fixed scaffolds were 
submerged in 1 vol% osmium tetroxide in PBS at room temperature for 2 hours before 
sequential dehydration in graded ethanol (50, 70, 80, 90, 100, 100 vol%) for ten minutes at 
each step. Finally, samples were immersed in 100% Hexamethyldisilane (HMDS) for three 
minutes before leaving to air dry for 3 days. 
To image, all samples were mounted on a carbon tab, sputter coated with gold, then imaged 
using a Philips XL 30S FEG with an electron beam with an energy of 20 kV. Images were 
analyzed using the measurement tool in Image J. 
'%$$%	
	2
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Image J software was used to analyse the overall porosity distribution of the scaffold.  50 
pores were randomly choosen  from each scaffold SEM image and three scaffolds per each 
condition considered. The results were represented in Mean±SD of three samples per each 
condition.    
'%$'	)		
Statistical analysis was performed using Graphpad prism 7.0 software.  All the experiments 
were conducted two times with three samples for each condition (n=6). The results are 
presented as Mean±SD and two+way ANOVA and one+way ANOVA were used to evaluate 
the statistical significance with Tukey’s post+ hoc test for multiple comparisons. 
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On day 1, there was no significant difference in cell viability between PEG containing and 
pure PLA scaffolds. Similarly, by comparing the ratio of cell metabolic activity on the 
scaffolds to the seeding wells, there was no significant difference in seeding efficiency. The 
metabolic activity on all scaffolds increased over time indicating that cell proliferation was 
supported. By day 14 and 21 cell viability was significantly higher in the PEG containing 
scaffolds than the pure PLA scaffolds (p<0.01) (Fig. 1B) indicating that PEG containing 
scaffolds provided favorable conditions for cell growth and colonization. 
 *%'%	9	.)		2.68		
ALP and DNA quantification assays were performed on day 14. Normalized ALP activity 
was significantly higher on PLA75 scaffolds than PLA90 and PLA100 scaffolds (Fig. 2A, 
p<0.001). There was no difference between PLA100 and PLA90 scaffolds. Calcium 
deposition on day 21 was significantly higher on PLA75 scaffolds in comparison to PLA100 
and PLA90 (Fig. 2B, p<0.01). As with ALP, there was no significant difference between 
PLA100 and PLA90 calcium deposition as assayed on day 21 by ARS quantification. Both 
PEG containing scaffolds supported significantly higher collagen deposition that the pure 
PLA scaffold (Fig. 2C p<0.05), although there was no significant difference between the 
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PLA90 and PLA75 compositions. Overall, it can be seen that the inclusion of PEG has 
improved the osteogenic performance of these scaffolds, with PLA75 having the greatest 
positive effect on ALP activity and mineralized extracellular matrix production (ECM).   
Cell+biomaterial interaction is crucial as cells seeded into the scaffold have to maintain their 
phenotype, have a favorable cell–matrix interaction, and secrete large amounts of ECM. To 
facilitate this, the biomaterial must support cell attachment and proliferation [22].  In the 
current study, MLO+A5 cells’ proliferation throughout the scaffolds was confirmed by 
increasing metabolic activity over time. Proliferation was improved on PEG containing 
scaffolds, which enabled higher mineralization and collagen formation (Fig. 2). These results 
confirm that PLA+PEG scaffolds are highly compatible with this osteoblast cell line and 
support high levels of bone matrix formation, demonstrating their potential for bone tissue 
engineering.    
*%*%	)(			
SEM images were used to assess the porosity of scaffolds. The top and cross+sectional views 
indicated there were pores throughout all the scaffolds (Fig. 3A).   Larger pores were 
observed in the cross+sectional SEM images of PEG containing scaffolds (PLA75 and 
PLA90). The overall pore size distribution in all scaffold compositions is given in Fig. 3C. It 
can be seen that in the PLA75 composition, the inclusion of PEG has resulted in a smaller 
proportion of small pores (0+100 μm, p<0.01) and a greater proportion of larger pores (200+
300 μm, p<0.01). This indicates that inclusion of PEG alters the pore size distribution by 
favoring the formation of larger pores. As the porosity introduced by the porogen is the same 
for all polymer blends, these larger pores appear to form during the leaching stage by the 
merging of smaller pores. A potential mechanism for this is the rupture of thin polymer walls 
surrounding the pores that form as the solvent evaporates during the casting stage [23]. As 
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PEG is more hydrophilic than PLA, swells in water and is water soluble, when PEG content 
is increased, more of these thin walls rupture during leaching resulting in more large pores 
being formed [24], [25]. To assess how successfully cells penetrated into the porous network 
of the scaffolds, the cell seeded scaffolds were examined by SEM on day 7 (Fig. 3B). Cells 
were visible within all scaffold types and could be see covering the internal pores in cross+
sectional images.  
 A similar method has previously been used to develop 3D scaffolds, which had high 
porosity, and controllable macropore size and wall morphology  [26]. Porosity facilitates cell 
ingrowth and colonization of the scaffold, which is one of the most important considerations 
for tissue engineering [8], [10], [27]. The porosity of PLA/PEG/NaCl scaffolds has been 
reported to reach as high as 80% with high pore density and open+pore structure [27]. Here 
we demonstrated that this improved porosity is beneficial for long term cell growth of 
osteblastic bone cells. The MLO+A5 cells proliferated on the scaffolds and cells migrated 
through the pores across the scaffold and were well distributed, as confirmed by cross+
sectional SEM images of cells on day 7 of culture. 
*%-%		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The penetration of MLO+A5 cells into the scaffold and can be observed using Z+stack 
confocal images with a depth of 224 µm. Cell nuclei are displayed as red and actin as green 
(Fig. 4). In the controls, there are no cells hence they appear black as no autofluorescence 
was observed for any scaffold composition. The porous structure allowed cells to migrate into 
the internal network of the thick scaffold. Cell+cell interaction, nutrient transport, removal of 
biological waste from within the scaffold and the cell seeding efficiency are all affected by 
porosity of the scaffold. The correct porosity range is important, as cell penetration into the 
scaffold could be prevented by very small pores and very large pores are not favorable for 
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cell adhesion due to the reduced area for cells to colonize [28]–[30]. In the present study, we 
have observed that cells were well distributed over the scaffold and penetrated into the 
scaffold. 
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	
In this study, we developed 3D porous PLA+PEG scaffolds using solvent casting+porogen 
leaching. We have observed that PEG improved the porous structure by altering the pore size 
distribution to increase pore size without increasing total porosity. MLO+A5 cells were 
cultured on these PLA+PEG scaffolds to investigate the effect of PEG incorporation on cell 
proliferation and bone matrix formation. Initial cell attachment was not affected by the 
addition of PEG to PLA despite the effect on pore size distribution, but it was observed that 
scaffolds containing PEG supported greater metabolic activity enhanced over time, indicating 
a higher cell number. Cell ingrowth is crucial for a successful tissue+engineered bone 
scaffold, and this was observed here by SEM images and confocal imaging showing excellent 
cell migration into the scaffold.  ALP activity and mineralized matrix production was 
significantly increased in the composite scaffolds containing the highest ratio of PEG 
(PLA75). The present study suggests that PLA+PEG scaffolds could have major applications 
in bone tissue engineering and that PEG can be incorporated to improve osteogenic behavior. 	
 0#	
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5
		
5
	$! Mean±SD of RR fluorescence for (A) seeding efficiency by comparing day 1 cell 
attachment on scaffolds and seeding wells. There was no significant difference in seeding 
efficiency for any scaffold composition (B) increase in metabolic activity over time on each 
of the scaffold compositions. PLA90 and PLA75 supported significantly higher metabolic 
activity from day 14 onwards (**=p<0.01) (n=6). 
5
	 '! Mean±SD for (A) normalized ALP activity on day 14. PLA75 supported 
significantly higher ALP (**=p<0.01) than PLA90 and PLA100. (B) ARS calcium staining 
on day 21. PLA75 supported significantly more calcium deposition than PLA90 and PLA100 
(**=p<0.01) (C) DR80 collagen staining on day 21. PLA75 and PLA90 supported 
significantly higher collagen deposition than PLA100 (*=p<0.05) (n=6). 
5
	*!	SEM images of scaffolds. (A) shows top surface and cross+sectional views for each 
scaffold composition (no cells) (B) shows representative images of cell attachment and 
appearance for each composition. Cells are indicated by a blue arrow.  (C) pore size 
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distribution for each of the scaffold compositions. Pore sizes (µm
2
) were analyzed using 
ImageJ. PLA75 had a larger proportion of large pores and smaller proportion of small pores 
in comparison to the other two compositions (**=p<0.01). 
5
	 -!	 Representative confocal Z+stack images of MLO+A5 cells on each scaffold 
composition. Nuclei stained with propidium Iodide (PI, red) and actin with phalloidin+FITC 
(green). Individual channels and composites shown. Control scaffolds were not 
autofluorescent and therefore appeared black. (For interpretation of the reference to color in 
this figure legend, the reader is referred to the web version of this article.) 
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3. SEM images of scaffolds. (A) shows top surface and crosssectional views for each scaffold 
composition (no cells) (B) shows representative images of cell attachment and appearance for each 
composition. Cells are indicated by a blue arrow.  (C) pore size distribution for each of the scaffold 
compositions. Pore sizes (µm2) were analyzed using ImageJ. PLA75 had a larger proportion of large pores 
and smaller proportion of small pores in comparison to the other two compositions (**=p<0.01).  
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